December 16, 2020
bioMérieux announces the CE marking of its molecular biology ARGENE® test for the simultaneous detection of SARS-CoV-2, influenza viruses A and B, and RSV and hMPV viruses
|
December 14, 2020
Increased outlook for full-year 2020
|
December 14, 2020
The French bioproduction sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training
|
December 02, 2020
BIOASTER, Université de Technologie de Compiègne, Hospices Civils de Lyon and bioMérieux formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology
|
November 16, 2020
bioMérieux announces the expansion of the CE marking of its molecular biology ARGENE® SARS-CoV-2 diagnostic test to include saliva specimens.
|